Be Ready to Manage Ketoacidosis Due to an SGLT2 Inhibitor
November 2023
You’ll get questions about how to manage euglycemic ketoacidosis due to SGLT2 inhibitors...as their use increases.
Ketoacidosis due to an SGLT2 inhibitor (SGLT2i) is rare...occurring in less than 0.1% of patients. And it’s easy to overlook...blood glucose is often normal or only slightly elevated.
Identification. Be alert for possible triggers of ketoacidosis in patients taking an SGLT2i, such as fasting...infection...reducing insulin doses...or surgery.
Get concise advice on drug therapy, plus unlimited access to CE
Hospital Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote